Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update
Go back to Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update| GALECTIN (NASDAQ: GALT) | Delayed: 3.88 +0.20 (5.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.68 | 52 Week High | $3.05 | |||
| Open | $3.68 | 52 Week Low | $0.49 | |||
| Day High | $3.97 | P/E | N/A | |||
| Day Low | $3.58 | EPS | $-1.32 | |||
| Volume | 227,962 | |||||

